[go: up one dir, main page]

BR9406332A - Mono-hidrato cristalino de espirostanil-glicosidal - Google Patents

Mono-hidrato cristalino de espirostanil-glicosidal

Info

Publication number
BR9406332A
BR9406332A BR9406332A BR9406332A BR9406332A BR 9406332 A BR9406332 A BR 9406332A BR 9406332 A BR9406332 A BR 9406332A BR 9406332 A BR9406332 A BR 9406332A BR 9406332 A BR9406332 A BR 9406332A
Authority
BR
Brazil
Prior art keywords
monohydrate
crystalline
spirostanyl glycoside
glycoside
crystalline spirostanyl
Prior art date
Application number
BR9406332A
Other languages
English (en)
Inventor
Douglas J M Allen
Harry A Watson Jr
Jonathan B Zung
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR9406332A publication Critical patent/BR9406332A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9406332A 1993-04-28 1994-01-19 Mono-hidrato cristalino de espirostanil-glicosidal BR9406332A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5444993A 1993-04-28 1993-04-28
PCT/US1994/000446 WO1994025479A1 (en) 1993-04-28 1994-01-19 Spirostanyl glycosidal crystalline monohydrate

Publications (1)

Publication Number Publication Date
BR9406332A true BR9406332A (pt) 1995-12-26

Family

ID=21991141

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9406332A BR9406332A (pt) 1993-04-28 1994-01-19 Mono-hidrato cristalino de espirostanil-glicosidal

Country Status (23)

Country Link
US (1) US5760009A (pt)
EP (1) EP0696292A1 (pt)
JP (1) JPH08504830A (pt)
CN (1) CN1121722A (pt)
AP (1) AP518A (pt)
AU (1) AU6295694A (pt)
BG (1) BG100098A (pt)
BR (1) BR9406332A (pt)
CA (1) CA2161239A1 (pt)
CZ (1) CZ280195A3 (pt)
FI (1) FI941942A7 (pt)
HU (1) HUT67142A (pt)
IL (1) IL109374A0 (pt)
LV (1) LV11475A (pt)
MA (1) MA23179A1 (pt)
NO (1) NO954322L (pt)
OA (1) OA10715A (pt)
PL (1) PL311278A1 (pt)
SI (1) SI9400203A (pt)
SK (1) SK135195A3 (pt)
WO (1) WO1994025479A1 (pt)
YU (1) YU22694A (pt)
ZA (1) ZA942772B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2074006B1 (es) * 1993-07-05 1996-03-16 Pfizer Glicosidos esteroidales para tratar hipercolesterolemia.
US6150336A (en) * 1995-05-29 2000-11-21 Pfizer Inc. Steroidal glycosides
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
EP1066033B1 (en) * 1998-03-26 2005-12-28 Phytopharm Plc Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US6343258B1 (en) 1999-08-13 2002-01-29 ALEXIS Brian Method for testing for readiness for harvesting of tribulus terrestris l. having high steroidal saponin content
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
PE20011061A1 (es) 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
US6562974B2 (en) 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
US6825960B2 (en) * 2002-01-15 2004-11-30 Inphase Technologies, Inc. System and method for bitwise readout holographic ROM
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2926463A1 (de) * 1978-07-05 1980-01-24 Roecar Holdings Nv Spiroketaline und ihre verwendung
US4260603A (en) * 1979-01-02 1981-04-07 Pegel Karl H Sterol glycoside with activity as prostaglandin synthetase inhibitor
NZ193564A (en) * 1979-05-02 1985-01-31 Aruba Pty Ltd Steroid alkaloids from solanum sodomeum and pharmaceutical compositions
JPS56120700A (en) * 1980-02-26 1981-09-22 Wakunaga Yakuhin Kk Cardiac stimmulant
US4602003A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia
US4602005A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis
US5010185A (en) * 1989-06-13 1991-04-23 Pfizer Inc. Processes for tigogenin beta-cellobioside
ATE165367T1 (de) * 1991-10-04 1998-05-15 Procter & Gamble Cholesterinsenkende verbindungen und verfahren zu ihrer herstellung
FI942394L (fi) * 1991-11-25 1994-05-24 Pfizer Menetelmä steroidiperasyyliglykosidien valmistamiseksi
US5629295A (en) * 1992-06-26 1997-05-13 Pfizer Inc. Steroidal glycosides for treating hypercholesterolemia
US5530107A (en) * 1992-10-15 1996-06-25 Pfizer Inc. Method for making steroidal peracyl glycosides
JP2767530B2 (ja) * 1993-05-06 1998-06-18 花王株式会社 物品の集荷方法及び装置

Also Published As

Publication number Publication date
FI941942A0 (fi) 1994-04-27
NO954322D0 (no) 1995-10-27
OA10715A (en) 2002-12-09
JPH08504830A (ja) 1996-05-28
AP518A (en) 1996-08-23
YU22694A (sh) 1997-03-07
FI941942L (fi) 1994-10-29
CN1121722A (zh) 1996-05-01
MA23179A1 (fr) 1994-12-31
BG100098A (bg) 1996-04-30
IL109374A0 (en) 1994-07-31
CA2161239A1 (en) 1994-11-10
FI941942A7 (fi) 1994-10-29
AP9400615A0 (en) 1994-01-31
EP0696292A1 (en) 1996-02-14
WO1994025479A1 (en) 1994-11-10
HU9401209D0 (en) 1994-08-29
CZ280195A3 (en) 1996-02-14
SI9400203A (en) 1995-06-30
US5760009A (en) 1998-06-02
HUT67142A (en) 1995-02-28
AU6295694A (en) 1994-11-21
LV11475A (lv) 1996-08-20
ZA942772B (en) 1995-10-23
PL311278A1 (en) 1996-02-05
SK135195A3 (en) 1996-03-06
NO954322L (no) 1995-10-27

Similar Documents

Publication Publication Date Title
FI954250L (fi) Kiteinen vapaa keftiofuurihappo
DK0626155T3 (da) Absorberbar medullaprop
ATE151861T1 (de) Verdampfer
DE69307078D1 (de) Kühlschrank
BR9407771A (pt) Mecanismo de auto-travamento
FI942313L (fi) Välituote atsitromysiiniä varten
DK76193D0 (da) Kulhydratderivater
FI945674A7 (fi) Substituoidut 2beta-morfoliini-androstaanijohdannaiset
BR9406332A (pt) Mono-hidrato cristalino de espirostanil-glicosidal
FI951613A7 (fi) Kaksoissuihkukiteytyslaite
NO303938B1 (no) Antibiotiske forbindelser
DE69406255D1 (de) Carbonatderivate
SE516608E (sv) Evaporator
DE69306875D1 (de) Verdampfereinheit
DE69621471D1 (de) Kristalline antimikrobielle Zusammensetzung
FI970828A7 (fi) Spirostanyyliglykosidien kiteitä
DE69210199D1 (de) Kühlschrank
DE59410459D1 (de) p-DINITROSO-BENZOL
FI944281L (fi) Anomeeriset fluoriribosyyliamiinit
DE69415710D1 (de) Verdampfer
FI963007A7 (fi) Haihdutin
DE59401079D1 (de) Kühlschrank
FI961177L (fi) Uusia aminoglykosidien suoloja
KR930015207U (ko) 냉장고의 제상장치
LV10450A (lv) O-heteroaril- O-alkilheteroaril- O-alkenilheteroaril- un O-alkinilheteroaril- makrolidi

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal